mhurhangee/ep-ind-claims huggingface dataset:
A nucleic acid biomarker set for predicting or diagnosing a disease related to microbiota in a subject or determining whether a subject is at the risk of developing the disease, comprising: MLG 5045 consisting of nucleic acid with the sequence of SEQ ID NO: 3732-3918; and MLG 121 consisting of nucleic acids with the sequence of SEQ ID NO: 3919-6548; optionally, the biomarker set further comprises one or more of the following: MLG 75 consisting of nucleic acids with the sequence of SEQ ID NO: 1350-1527; MLG 109 consisting of nucleic acids with the sequence of SEQ ID NO: 6549-7235; MLG 317 consisting of nucleic acids with the sequence of SEQ ID NO: 7581-7700; MLG 135 consisting of nucleic acids with the sequence of SEQ ID NO: 2230-3731; MLG 223 consisting of nucleic acids with the sequence of SEQ ID NO: 9892-11298; MLG 100 consisting of nucleic acids with the sequence of SEQ ID NO: 9596-9891; MLG 219 consisting of nucleic acids with the sequence of SEQ ID NO: 7701-8028; MLG 114 consisting of nucleic acids with the sequence of SEQ ID NO: 1528-2089; MLG 84 consisting of nucleic acids with the sequence of SEQ ID NO: 1-165; MLG 166 consisting of nucleic acids with the sequence of SEQ ID NO: 7236-7580; MLG 2985 consisting of nucleic acids with the sequence of SEQ ID NO: 8029-9595; MLG 131 consisting of nucleic acids with the sequence of SEQ ID NO: 166-1349; and MLG 1564 consisting of nucleic acids with the sequence of SEQ ID NO: 2090-2229; preferably, the biomarker set comprises the nucleic acid biomarkers as defined in -, wherein the disease is colorectal carcinoma. MLG 5045 consisting of nucleic acid with the sequence of SEQ ID NO: 3732-3918; and MLG 121 consisting of nucleic acids with the sequence of SEQ ID NO: 3919-6548; optionally, the biomarker set further comprises one or more of the following: MLG 75 consisting of nucleic acids with the sequence of SEQ ID NO: 1350-1527; MLG 109 consisting of nucleic acids with the sequence of SEQ ID NO: 6549-7235; MLG 317 consisting of nucleic acids with the sequence of SEQ ID NO: 7581-7700; MLG 135 consisting of nucleic acids with the sequence of SEQ ID NO: 2230-3731; MLG 223 consisting of nucleic acids with the sequence of SEQ ID NO: 9892-11298; MLG 100 consisting of nucleic acids with the sequence of SEQ ID NO: 9596-9891; MLG 219 consisting of nucleic acids with the sequence of SEQ ID NO: 7701-8028; MLG 114 consisting of nucleic acids with the sequence of SEQ ID NO: 1528-2089; MLG 84 consisting of nucleic acids with the sequence of SEQ ID NO: 1-165; MLG 166 consisting of nucleic acids with the sequence of SEQ ID NO: 7236-7580; MLG 2985 consisting of nucleic acids with the sequence of SEQ ID NO: 8029-9595; MLG 131 consisting of nucleic acids with the sequence of SEQ ID NO: 166-1349; and MLG 1564 consisting of nucleic acids with the sequence of SEQ ID NO: 2090-2229; preferably, the biomarker set comprises the nucleic acid biomarkers as defined in -, wherein the disease is colorectal carcinoma.
A liquid telechelic prepolymer comprising the reaction product of a telechelic polyamide and a polyisocyanate having two or more isocyanate groups, the telechelic polyamide is characterized as having repeating units connected by linkages between the repeating units and having two or more Zerewitinoff groups that chemically react with isocyanate groups to form a chemical bond between a portion of said Zerewitinoff groups and the isocyanate group, said Zerewitinoff groups being active-hydrogen-containing groups which are reactive with isocyanates to form chemical bonds, further wherein the telechelic polyamide comprises repeat units connected with chemical linkages characterized as being amide linkages and at least 80 % of the amide linkages are characterized as being tertiary amide linkages, characterized in that said telechelic prepolymer is the reaction product of a hydroxyl terminated polyamide with a polyisocyanate and said telechelic polyamide is comprised of one or more repeat units from a lactone of 2 or 4 to 10 carbon atoms and/or a hydroxyl carboxylic acid of 3 to 30 carbon atoms, wherein said lactone and/or hydroxyl carboxylic acid are added after polymerization of an amine-terminated polyamide to convert it to a hydroxyl-terminated polyamide by being the terminal repeat unit(s) on one or both ends of said telechelic polyamide.
A milking system, comprising a milking device for milking a milking from a dairy animal during a milking operation and a control unit for the milking system, and provided with: - a plurality of milking cups, each ending in a milk hose, - a first milk jar connected to the milk hoses which is configured to receive the milking, and provided with a first closable milk outflow, - a first milk pipeline which is in flow communication with the first milk outflow, - a first pumping device which is configured to pump the milking from the first milk jar into the first milk pipeline, - at least one storage tank for receiving and storing at least a part of the milking via the first milk pipeline, further comprising a second milk jar, which is attached in flow communication to the first milk pipeline for receiving the milking therefrom out of the first milk jar, and which is provided with a second milk outflow, a second milk pipeline, which is attached in flow communication to the second milk outflow and to the at least one storage tank, and a second pumping device which is configured to pump at least a part of the milking from the second milk jar into the second milk pipeline, characterized in that the second pumping device pumps the milking through the second milk pipeline at a lower flow rate than the first pumping device pumps said milking through the first milk pipeline. - a plurality of milking cups, each ending in a milk hose, - a first milk jar connected to the milk hoses which is configured to receive the milking, and provided with a first closable milk outflow, - a first milk pipeline which is in flow communication with the first milk outflow, - a first pumping device which is configured to pump the milking from the first milk jar into the first milk pipeline, - at least one storage tank for receiving and storing at least a part of the milking via the first milk pipeline, further comprising a second milk jar,
A battery module comprising a plurality of battery cells, a module housing storing the battery cells, and a gap-filling material loaded in the module housing, wherein the battery cell is in a flat shape having flat surfaces and includes a flexible film pouch storing battery elements; and the gap-filling material is made of a silicone elastic material containing a thermally conductive filler and having hardness of 80 or more in terms of E hardness complying with JIS K6253 or 60 or more in terms of A hardness complying with JIS K6253, wherein the silicone elastic material is formed by a cured material of an addition-reaction curable type silicone mixed from a main agent and curing agents, wherein the gap-filling material is loaded between the battery cells and between the battery cell and the module housing on one side in a direction intersecting a direction in which the battery cells are arrayed side by side with the flat surfaces of the battery cells facing each other, and covering 20 to 40% on the said one side of the battery cells, and adheres to the battery cells for retaining a space between the battery cells and for conducting heat generated by the battery cells to the module housing, wherein there is a gap in the portion of the module housing that is not filled with the gap-filling material. wherein the battery cell is in a flat shape having flat surfaces and includes a flexible film pouch storing battery elements; and the gap-filling material is made of a silicone elastic material containing a thermally conductive filler and having hardness of 80 or more in terms of E hardness complying with JIS K6253 or 60 or more in terms of A hardness complying with JIS K6253, wherein the silicone elastic material is formed by a cured material of an addition-reaction curable type silicone mixed from a main agent and curing agents, wherein the gap-filling material is loaded between the battery cells and between the battery cell and the module housing on one side in a direction intersecting a direction in which the battery cells are arrayed side by side with the flat surfaces of the battery cells facing each other, and covering 20 to 40% on the said one side of the battery cells, and adheres to the battery cells for retaining a space between the battery cells and for conducting heat generated by the battery cells to the module housing, wherein there is a gap in the portion of the module housing that is not filled with the gap-filling material.
A method performed by a computerized moderator control system for merging a first conference with a second conference to create a single heterogeneous conference, wherein the first conference and the second conference utilize different conference hosting systems that are coupled together through a server, and the first conference has an associated first pre-merge moderator and the second conference has an associated second pre-merge moderator; the method comprising: merging the first conference with the second conference to create the heterogeneous conference by sending a merge control to the server to establish conference connections with the conference hosting systems of the conferences being merged; determining a moderator for the heterogeneous conference; and automatically transferring one or more moderator controls to the moderator of the heterogeneous conference, wherein exercising moderator control comprises sending a control to the server or to the conference hosting systems. merging the first conference with the second conference to create the heterogeneous conference by sending a merge control to the server to establish conference connections with the conference hosting systems of the conferences being merged; determining a moderator for the heterogeneous conference; and automatically transferring one or more moderator controls to the moderator of the heterogeneous conference, wherein exercising moderator control comprises sending a control to the server or to the conference hosting systems.
A method for dewatering a solution, the method comprising: introducing a feed solution comprising water and a permeable solute into a first side of a forward osmosis system; circulating a draw solution through a second side of the forward osmosis system, the draw solution having a concentration of said permeable solute greater than or equal to the concentration of said permeable solute in the feed solution; generating a diluted draw solution in the second side of the forward osmosis system, the diluted draw solution having a higher water concentration than the draw solution; and producing a product stream including a concentrated feed solution from the first side of the forward osmosis system, the concentrated feed solution having a concentration of said permeable solute greater than or equal to the concentration of said permeable solute in the feed solution. introducing a feed solution comprising water and a permeable solute into a first side of a forward osmosis system; circulating a draw solution through a second side of the forward osmosis system, the draw solution having a concentration of said permeable solute greater than or equal to the concentration of said permeable solute in the feed solution; generating a diluted draw solution in the second side of the forward osmosis system, the diluted draw solution having a higher water concentration than the draw solution; and producing a product stream including a concentrated feed solution from the first side of the forward osmosis system, the concentrated feed solution having a concentration of said permeable solute greater than or equal to the concentration of said permeable solute in the feed solution.
A cosmetic composition comprising: (i) microspheres for providing soft-focus benefits where said microspheres comprise at least 50% cellulose by weight of microspheres; and, (ii) 0.5 to 10 wt% of a non-silica hydrophilic inorganic thickener; wherein refractive index of said microspheres is from 1.42 to 1.50. (i) microspheres for providing soft-focus benefits where said microspheres comprise at least 50% cellulose by weight of microspheres; and, (ii) 0.5 to 10 wt% of a non-silica hydrophilic inorganic thickener; wherein refractive index of said microspheres is from 1.42 to 1.50.
A battery management system comprising: a plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) configured to measure information about a battery and generate an activation signal (S AT1 - S ATN) according to an operating state; and a main BMS (900_M) configured to receive the activation signal (S AT1 -S ATN) to determine the operating state of the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N), and generate and transfer a synchronization signal to the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) if the plurality of sub-BMSs operate in a power-on state, wherein the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) are configured to measure current information of the battery in synchronisation with a time point at which the voltage of the battery is measured according to the synchronization signal. a plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) configured to measure information about a battery and generate an activation signal (S AT1 - S ATN) according to an operating state; and a main BMS (900_M) configured to receive the activation signal (S AT1 -S ATN) to determine the operating state of the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N), and generate and transfer a synchronization signal to the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) if the plurality of sub-BMSs operate in a power-on state, wherein the plurality of sub-BMSs (900_S 1, 900_S 2....900_S N) are configured to measure current information of the battery in synchronisation with a time point at which the voltage of the battery is measured according to the synchronization signal.
Human Transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder selected from the group consisting of retinitis Pigmentosa, age-related macular degeneration, aceruloplasminemia, Bardet-Biedel syndrome, Bassen-Kornzweig syndrome, Best disease, choroidema, gyrate atrophy, Leber congenital amaurosis, Refsum disease, Stargardt disease, cataract, glaucomatous neuropathy and retinopathy of prematury.
A steam engine comprising a sealed container suitable for containing a liquid therein, a steam-generating portion arranged under the sealed container being communicated with the sealed container to generate the steam of the liquid, and a condenser arranged over the sealed container being communicated with the sealed container to condense the steam of the liquid, wherein a rotor having a plurality of displacement chambers and a plurality of partitioning walls formed among the displacement chambers is provided in the sealed container; the rotor is rotatably supported by the sealed container and is dipped in the liquid; and a flow-out passage is provided on the upper portion of the steam generating portion; so that steam of the liquid generated by heating the steam-generating portion is fedable to the displacement chambers of the rotor from the flow-out passage and the steam engine is suitable for buoyancy acting on one side of the rotor so as to rotate the rotor, characterized in that the partitioning walls of the rotor extend straight from the root portion of the rotor so as to be tilted rearward in the direction in which the rotor is rotatable, and the flow-out passage is set in the tangential direction in which the rotor is rotatable, such that the steam engine is suitable for the steam of the liquid to impart a rotational torque of collision to the partitioning walls.
An absorbent article (10, 20, 300, 500, 600) comprising an absorbent core (101, 501, 601) sandwiched between a liquid permeable topsheet (520, 620) and a liquid impermeable backsheet (521, 621), wherein the absorbent core (101, 501, 601) comprises absorbent material selected from the group consisting of cellulose fibers, superabsorbent polymers and combinations thereof, wherein said absorbent material is contained within at least one core wrap substrate enclosing said absorbent material, and wherein a top layer of said core wrap is adhered to a bottom layer of said core wrap to form one or more channels substantially free of said absorbent material, wherein said channels have a length extending along a longitudinal axis and the absorbent core (101, 501, 601) has a length extending along said longitudinal axis and wherein the length of said channels is from 10% to 95% of the length of said absorbent core (101, 501, 601) such that each said channels are circumscribed by absorbent material characterized in that said top layer of the core wrap is in direct contact with the topsheet, and said top layer of the core wrap comprises a spunbond nonwoven or a carded thermobonded nonwoven and in that the top layer of the core wrap is directly joined to the topsheet by adhesive located at discrete joining areas spaced apart in the transverse direction.
A method for receiving, by a station, STA, a signal from an access point, AP, related to a plurality of basic service sets, BSSs, in a wireless local area network, LAN, system, the method comprising: receiving, from the AP, a frame including information on the plurality of BSSs, wherein the information on the plurality of BSSs includes information on a plurality of BSS identifiers, BSSIDs, and information on a BSS color for the plurality of BSSs, wherein each of the plurality of BSSIDs is set to a value that is different per individual BSS, and the BSS color is set to a value that is identical for the plurality of BSS; receiving a physical layer protocol data unit, PPDU, which has a same BSS color as the BSS color of a BSS associated with the STA and does not include an identifier of the STA, wherein the PPDU is determined as an intra-BSS PPDU based on the same BSS color; and entering a doze state until an end of the PPDU based on the received PPDU. receiving, from the AP, a frame including information on the plurality of BSSs, wherein the information on the plurality of BSSs includes information on a plurality of BSS identifiers, BSSIDs, and information on a BSS color for the plurality of BSSs, wherein each of the plurality of BSSIDs is set to a value that is different per individual BSS, and the BSS color is set to a value that is identical for the plurality of BSS; receiving a physical layer protocol data unit, PPDU, which has a same BSS color as the BSS color of a BSS associated with the STA and does not include an identifier of the STA, wherein the PPDU is determined as an intra-BSS PPDU based on the same BSS color; and entering a doze state until an end of the PPDU based on the received PPDU.
A positive resist composition, which comprises an acid-decomposable resin having (i) a repeating unit having a group having a lactone structure, and (ii) a repeating unit derived from a monomer having a structure showing a basicity at the side chain and capable of increasing the solubility in an alkali developer by the action of an acid. (i) a repeating unit having a group having a lactone structure, and (ii) a repeating unit derived from a monomer having a structure showing a basicity at the side chain and capable of increasing the solubility in an alkali developer by the action of an acid.
A system for provisioning a secure terminal comprising: a provisioning device; and one or more non-transitory computer-readable mediums accessible to one or more processors, and storing instructions which, when executed by the one or more processors, cause the system to: receive, at the provisioning device, a key validation request for a secure terminal key, from the secure terminal, wherein the key validation request comprises a request to validate the key; parse the key validation request on the provisioning device; generate, on the provisioning device and in response to receiving the key validation request, both a key validation and a trusted time stamp, send, from the provisioning device, the key validation and the trusted time stamp to the secure terminal, characterized in that the secure terminal is configured to store the key validation if an elapsed time since the trusted time stamp was generated is below a predetermined threshold. a provisioning device; and one or more non-transitory computer-readable mediums accessible to one or more processors, and storing instructions which, when executed by the one or more processors, cause the system to: receive, at the provisioning device, a key validation request for a secure terminal key, from the secure terminal, wherein the key validation request comprises a request to validate the key; parse the key validation request on the provisioning device; generate, on the provisioning device and in response to receiving the key validation request, both a key validation and a trusted time stamp, send, from the provisioning device, the key validation and the trusted time stamp to the secure terminal, characterized in that the secure terminal is configured to store the key validation if an elapsed time since the trusted time stamp was generated is below a predetermined threshold. receive, at the provisioning device, a key validation request for a secure terminal key, from the secure terminal, wherein the key validation request comprises a request to validate the key; parse the key validation request on the provisioning device; generate, on the provisioning device and in response to receiving the key validation request, both a key validation and a trusted time stamp, send, from the provisioning device, the key validation and the trusted time stamp to the secure terminal, characterized in that the secure terminal is configured to store the key validation if an elapsed time since the trusted time stamp was generated is below a predetermined threshold.
A method for coating a medical device comprising a first layer comprising a first drug, wherein the first layer is free from polymers and the first drug is an antiproliferative agent, the method comprising: applying a solution comprising a second drug and a solvent to form a second layer on the first layer of the medical device, wherein the second drug is an anti-inflammatory agent and the second layer is free from polymers, wherein the first drug in the first layer is in crystalline form and wherein the solution comprising the second drug is applied to the first layer of the medical device such that the first drug maintains its crystalline form.